Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example

Purpose: Genetic risk assessment is becoming an important component of clinical decision-making. Genetic Risk Scores (GRSs) allow the composite assessment of genetic risk in complex traits. A technically and clinically pertinent question is how to most easily and effectively combine a GRS with an assessment of clinical risk derived from established non-genetic risk factors as well as to clearly present this information to patient and health care providers. Materials and Methods: We illustrate a means to combine a GRS with an independent assessment of clinical risk using a log-link function. We apply the method to the prediction of coronary heart disease (CHD) in the Atherosclerosis Risk in Communities (ARIC) cohort. We evaluate different constructions based on metrics of effect change, discrimination, and calibration. Results: The addition of a GRS to a clinical risk score (CRS) improves both discrimination and calibration for CHD in ARIC. Results are similar regardless of whether external vs. internal coefficients are used for the CRS, risk factor single nucleotide polymorphisms (SNPs) are included in the GRS, or subjects with diabetes at baseline are excluded. We outline how to report the construction and the performance of a GRS using our method and illustrate a means to present genetic risk information to subjects and/or their health care provider. Conclusion: The proposed method facilitates the standardized incorporation of a GRS in risk assessment.

[1]  R. Green,et al.  Personalized Genetic Risk Counseling to Motivate Diabetes Prevention , 2012, Diabetes Care.

[2]  Andrew G. Ury,et al.  Storing and interpreting genomic information in widely deployed electronic health record systems , 2013, Genetics in Medicine.

[3]  E. Ingelsson,et al.  Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Matthew C Keller,et al.  Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease risk , 2011, BMC Medical Genetics.

[5]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[6]  L. Palmer.  UK Biobank: bank on it , 2007, The Lancet.

[7]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[8]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[9]  D. Absher,et al.  Randomized Trial of Personal Genomics for Preventive Cardiology: Design and Challenges , 2012, Circulation. Cardiovascular genetics.

[10]  Nancy R. Cook,et al.  Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.

[11]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[12]  Keith Marsolo,et al.  Clinical genomics in the world of the electronic health record , 2013, Genetics in Medicine.

[13]  J. Ioannidis,et al.  Consistency of genome-wide associations across major ancestral groups , 2011, Human Genetics.

[14]  Nancy R Cook,et al.  Statins: new American guidelines for prevention of cardiovascular disease , 2013, The Lancet.

[15]  John P A Ioannidis,et al.  More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines. , 2014, JAMA.

[16]  A. Peters,et al.  Genetic Markers Enhance Coronary Risk Prediction in Men: The MORGAM Prospective Cohorts , 2012, PloS one.

[17]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[18]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[19]  Doug Speed,et al.  Improved heritability estimation from genome-wide SNPs. , 2012, American journal of human genetics.

[20]  A. Folsom,et al.  Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. , 1996, Journal of clinical epidemiology.

[21]  John P A Ioannidis,et al.  What makes a good predictor?: the evidence applied to coronary artery calcium score. , 2010, JAMA.

[22]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[23]  Joan Scott,et al.  Preferences for opt-in and opt-out enrollment and consent models in biobank research: a national survey of Veterans Administration patients , 2012, Genetics in Medicine.

[24]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[25]  Simon Cawley,et al.  Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. , 2011, Genomics.

[26]  A. Yashin,et al.  Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins , 2002, Journal of internal medicine.

[27]  A. Hofman,et al.  A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. , 2012, Atherosclerosis.

[28]  G. Howard,et al.  Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation. , 2014, Circulation.

[29]  Nancy R Cook,et al.  A Bias-Corrected Net Reclassification Improvement for Clinical Subgroups , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.

[30]  V. Salomaa,et al.  Genetic Risk Prediction and a 2-Stage Risk Screening Strategy for Coronary Heart Disease , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Pui-Yan Kwok,et al.  Design and coverage of high throughput genotyping arrays optimized for individuals of East Asian, African American, and Latino race/ethnicity using imputation and a novel hybrid SNP selection algorithm. , 2011, Genomics.

[32]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[33]  Kathleen F. Kerr,et al.  Net reclassification indices for evaluating risk prediction instruments: a critical review. , 2014, Epidemiology.

[34]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[35]  Tim Sprosen,et al.  UK Biobank: from concept to reality. , 2005, Pharmacogenomics.

[36]  Melissa A. Basford,et al.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.

[37]  J. Zimmerman,et al.  Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited* , 2007, Critical care medicine.

[38]  T. Therneau,et al.  Assessing calibration of prognostic risk scores , 2016, Statistical methods in medical research.

[39]  Jing Cui,et al.  Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score , 2009, The Lancet Neurology.

[40]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[41]  C. O’Donnell,et al.  Genomic medicine for improved prediction and primordial prevention of cardiovascular disease. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[42]  Udo Hoffmann,et al.  A Genetic Risk Score Is Associated With Incident Cardiovascular Disease and Coronary Artery Calcium: The Framingham Heart Study , 2012, Circulation. Cardiovascular genetics.

[43]  Abel N. Kho,et al.  Practical challenges in integrating genomic data into the electronic health record , 2013, Genetics in Medicine.

[44]  J. Danesh,et al.  Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .

[45]  Hester F. Lingsma,et al.  Assessing the incremental value of diagnostic and prognostic markers: a review and illustration , 2012, European journal of clinical investigation.

[46]  N. Cook,et al.  Response to Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation. , 2014, Circulation.